Keeley Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Keeley Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$602K	Sell	16,603 -40,266	-71%	-$1.61M	0.03%	226
2016 Q3	$2.62M	Sell	56,869 -1,300	-2%	-$67.8K	0.11%	112
2016 Q2	$2.92M	Buy	58,169 +14,385	+33%	+$766K	0.12%	111
2016 Q1	$2.34M	Buy	43,784 +7,399	+20%	+$434K	0.09%	134
2015 Q4	$2.39M	Buy	36,385 +395	+1%	+$24.4K	0.08%	136
2015 Q3	$2.03M	Sell	35,990 -290	-0.8%	-$18.8K	0.06%	183
2015 Q2	$2.14M	Sell	36,280 -555	-2%	-$34.2K	0.05%	194
2015 Q1	$2.29M	Sell	36,835 -1,120	-3%	-$65.1K	0.05%	201
2014 Q4	$2.18M	Sell	37,955 -9,755	-20%	-$543K	0.04%	214
2014 Q3	$2.56M	Buy	47,710 +275	+0.6%	+$14.6K	0.05%	197
2014 Q2	$2.49M	Hold	47,435	–	–	0.04%	217
2014 Q1	$2.51M	Buy	+47,435	New	+$2.19M	0.04%	222

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Keeley Asset Management's TEVA Position: Q4 2016 in Review

Keeley Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 71% in Q4 2016, selling an estimated $1.61M and leaving 16,603 shares worth $602K. The position accounts for 0.03% of the portfolio, ranked #226.

Keeley Asset Management first reported a position in TEVA in Q1 2014 and has held it in 12 quarters since. The position peaked at $2.92M in Q2 2016. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Keeley Asset Management held 16,603 shares of Teva Pharmaceuticals worth $602K as of Q4 2016.
Keeley Asset Management sold 40,266 Teva Pharmaceuticals shares in Q4 2016, an estimated $1.61M.
Teva Pharmaceuticals made up 0.03% of Keeley Asset Management's portfolio in Q4 2016, its #226 holding.
Keeley Asset Management first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 12 quarters since.
Keeley Asset Management's Teva Pharmaceuticals position peaked at $2.92M in Q2 2016.
739 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Keeley Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.